Measuring the function of children with juvenile arthritis

A Tennant1, S Kearns, F Turner

  • 1Rheumatology & Rehabilitation Research Unit, School of Medicine, The University of Leeds, Leeds, UK.

Insights

This study validated disability measures for juvenile idiopathic arthritis (JIA) in UK children. The Childhood Health Assessment Questionnaire (CHAQ) is recommended until better options are available.

Area of Science:

  • Pediatric Rheumatology
  • Clinical Assessment Tools
  • Childhood Disability Measurement

Background:

  • Juvenile idiopathic arthritis (JIA) significantly impacts childhood development and daily activities.
  • Existing disability measures for JIA lack validation for use in the UK population.
  • There is a need for reliable and validated functional assessment tools for children with JIA in the UK.

Purpose of the Study:

  • To compare and validate four established disability measures for JIA.
  • To assess a locally developed functional test for JIA in UK children.
  • To identify the most suitable measure for assessing function in pediatric arthritis.

Main Methods:

  • Recruited 53 children aged 5-16 years with JIA (mean age 10.4 years, disease duration 4 years).
  • Evaluated five different disability and function measures, including a local functional test.
  • Assessed internal consistency, reliability, and unidimensionality of the measures.

Main Results:

  • Three of the five measures demonstrated adequate internal consistency.
  • Four measures showed statistically significant associations between disease activity and functional status (P<0.05).
  • Measures involving direct therapist assessment exhibited poor reliability, and most lacked unidimensionality.

Conclusions:

  • The Childhood Health Assessment Questionnaire (CHAQ) is currently the most recommended measure for assessing function in children with JIA.
  • Further development of validated assessment tools for pediatric arthritis in the UK is warranted.
  • The CHAQ provides a reliable option for functional assessment in JIA pending new measure availability.
Abstract

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...